A detailed history of Kestra Advisory Services, LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 13,110 shares of ALT stock, worth $105,535. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,110
Previous 11,979 9.44%
Holding current value
$105,535
Previous $79,000 1.27%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.5 - $8.1 $6,220 - $9,161
1,131 Added 9.44%
13,110 $80,000
Q2 2024

Aug 14, 2024

BUY
$5.91 - $10.23 $70,795 - $122,545
11,979 New
11,979 $79,000

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $395M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.